Hand Acupuncture for Sudden Worsening of Bronchial Asthma in Adults
Tests hand acupuncture alongside standard medicine in adults with worsening bronchial asthma.
Plain-language title generated from the registry record
Registry title: Evaluation of Clinical Effect of Acupuncture on Acute Exacerbation of Bronchial Asthma
Key facts
- Where
- Zhengzhou, ChinaSee the site
Where in China
- The First Affiliated Hospital of Henan University of Chinese MedicineZhengzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Henan University of Traditional Chinese Medicine
- Trial code
- NCT07632352
- Record updated
- 8 June 2026
- Original description
Based on the bioholographic theory, this study preliminarily explores the clinical efficacy of hand acupuncture in treating acute exacerbation of bronchial asthma and evaluates its immediate anti-asthmatic effect, so as to provide a new therapeutic strategy for the clinical management of bronchial asthma.Read full original descriptionShow less
Evaluation of Clinical Effect of Acupuncture on Acute Exacerbation of Bronchial Asthma Based on Biological Holography Theory
Based on the bioholographic theory, this study preliminarily explores the clinical efficacy of hand acupuncture in treating acute exacerbation of bronchial asthma and evaluates its immediate anti-asthmatic effect, so as to provide a new therapeutic strategy for the clinical management of bronchial asthma.
Inclusion: Patients meeting the Western medicine diagnostic criteria for acute exacerbation of bronchial asthma; Aged ≥ 18 years old; Voluntarily receive treatment and sign the informed consent form.
Exclusion: Patients suffering from other severe systemic diseases such as diseases of the circulatory system, hematological system and nervous system; Those who fail to meet the inclusion criteria; Pregnant or lactating women; Subjects enrolled but not treated per the study protocol; Patients who have participated in other clinical trials of medicinal products within 3 months; Other circumstances deemed ineligible for enrollment by researchers.